Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-12

Clinical Trial Update: Sequential or CombinaTion Anti-obesitY Medication With Muscle Preservation for Weight Loss and MaintEnance: A PragmAtic Randomized CoNtrolled Trial (STAY-LEAN Trial) [Phase 4]

View source ↗

Summary

This Phase 4 pragmatic randomized trial investigates sequential or combination anti-obesity medications with the goal of reducing weight while preserving muscle…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The Cleveland Clinic | Conditions: Obesity | Phase 4 | Status: ACTIVE_NOT_RECRUITING